Demand for Artificial Pancreas Device System in Japan

Future Market Insights

Key Insight

The demand for artificial pancreas device system in Japan is projected to grow from USD 17.4 million in 2025 to USD 32.8 million by 2035, at a CAGR of 6.5%. Threshold Suspend Device System will dominate with a 72.5% market share, while diabetes type i will lead the indication segment with a 56.3% share.

December 12, 2025

Anurag Sharma

250 Pages

Cite this Report

Demand for Artificial Pancreas Device System in Japan

https://www.futuremarketinsights.com/reports/japan-artificial-pancreas-device-system-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Beta Bionics Inc
Insulet Corporation
Medtronic plc
Tandem Diabetes Care

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Artificial Pancreas Device System in Japan

Key Players

Similar Industry Reports